相关实验视频

Updated: Jul 5, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

肝转移中的Rap1通路相关基因表达状态与相应的初级结肠直肠癌相比

Maryam Abbastabar^1,2, Heike Allgayer³, Mahdi Sepidarkish⁴

¹Student Research Committee, Babol University of Medical Sciences, Babol 47176-47745, Iran.

|January 11, 2024

概括

这项研究研究了结直肠癌肝转移 (CRLM) 中的Rap1通路基因. NRAS,FGF1和KDR在转移组织中表达更高,这表明它们在转移中的作用和潜在的诊断标记.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
癌症研究癌症研究

背景情况:

结直肠癌肝转移 (CRLM) 分子网络尚未完全理解.
识别转移的分子驱动因素对于向治疗至关重要.

研究的目的:

调查CRLM中的Rap1通路相关基因的表达.
评估这些基因在区分转移性和非转移性结直肠癌 (CRC) 的诊断潜力.

主要方法:

使用定量实时PCR (qRT-PCR) 和西部斑分析.
评估了NRAS,FGF1,NGF和KDR的基因和蛋白质表达.
对30名患者的配对CRC,相邻的非癌性和CRLM组织进行了分析.

主要成果:

在CRLM组织中,NRAS,FGF1和KDRmRNA和蛋白质水平明显高于原发性CRC和相邻的非癌性组织 (p <0.05).
在非转移性患者中,初级CRC和相邻的非癌性组织之间没有观察到NRAS,FGF1,KDR和NGF表达的显著差异 (p > 0.05).
接收器操作特征 (ROC) 曲线分析表明NRAS,FGF1,KDR和FGF的诊断准确性,根据原发性瘤分析来区分转移患者和非转移患者.

结论:

这些发现表明NRAS,FGF1和KDR在CRLM发展中发挥作用.
这些基因有潜力成为诊断结直肠癌转移的生物标志物.
对CRLM中的Rap1相关基因进行进一步的功能研究是有必要的,以推进治疗和预防策略.

关键词:

一个FGF1的FGF1.刚果民主共和国的人民共和国.国家自然资源基金 (NGF)它们是NRAS和NRAS.结肠直肠癌是什么意思大肠直肠癌肝脏转移

更多相关视频

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...